Comparative efficacy of combined oral contraceptives and the levonorgestrel 52 mg IUD.
Adherence
Combined oral contraceptives
Contraception
Efficacy
Intrauterine device
Levonorgestrel
Journal
European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672
Informations de publication
Date de publication:
22 Jul 2024
22 Jul 2024
Historique:
received:
10
06
2024
revised:
18
07
2024
accepted:
21
07
2024
medline:
26
7
2024
pubmed:
26
7
2024
entrez:
25
7
2024
Statut:
aheadofprint
Résumé
The relative risk of pregnancy with the levonorgestrel 52 mg IUD is 3 times lower than with optimal combined oral contraceptive use.
Identifiants
pubmed: 39054189
pii: S0301-2115(24)00399-3
doi: 10.1016/j.ejogrb.2024.07.044
pii:
doi:
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Creinin has received speaking honoraria from Gedeon Richter, Mayne, and Organon, has stock options with Femasys, and has consulted for Curai, Estetra SRL, Medicines360, and Organon. All other authors have no personal disclosures. The Department of Obstetrics and Gynecology, University of California, Davis, has received contraceptive research funding from Chemo Research SL, HRA Pharma, Medicines 360, Merck, and Sebela.